Who Owns Impact BioMedical Stock?
NYSE: IBOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 3:58 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 3.56%
- Held by insiders
- 89.02%
- Institutional holders
- 22
- Institutions 3.6%
- Insiders 89.0%
- Public and other 7.4%
Who owns Impact BioMedical stock?
Institutional investors own about 3.6% of Impact BioMedical's shares, spread across 22 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 89.02% of IBO.
The largest institutional holders are Geode Capital Management, LLC (1.10%), Vanguard Capital Management LLC (0.75%) and State Street Corporation (0.56%). Together, the top 10 institutions control 3.5% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their IBO positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of IBO
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Geode Capital Management, LLC | 93.91K | 1.10% | -0.7% |
| Vanguard Capital Management LLC | 64.08K | 0.75% | +14.2% |
| State Street Corporation | 48.17K | 0.56% | 0.0% |
| Vanguard Fiduciary Trust Co | 46.71K | 0.55% | +0.7% |
| Blackrock Inc. | 20.60K | 0.24% | 0.0% |
| Northern Trust Corporation | 18.66K | 0.22% | -3.5% |
| Citadel Advisors Llc | 3.93K | 0.05% | +100.0% |
| Vanguard Global Advisers, LLC | 2.55K | 0.03% | 0.0% |
| Jane Street Group, LLC | 1.94K | 0.02% | +100.0% |
| Two Sigma Investments, LP | 1.36K | 0.02% | -54.1% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of IBO
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 62.23K | 0.73% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 44.15K | 0.52% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 18.77K | 0.22% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 12.28K | 0.14% |
| John Hancock Variable Insurance Trust-Total Stock Market Index Trust | 180 | 0.00% |
Frequently asked questions
Who is the largest shareholder of Impact BioMedical?
Geode Capital Management, LLC is the largest institutional shareholder of IBO, owning 1.10% of shares outstanding (93.91K shares) as of its latest 13F filing.
What percentage of Impact BioMedical is owned by institutions?
Institutions own about 3.6% of IBO shares and 32.4% of the public float.
How much of Impact BioMedical do insiders own?
Insiders, such as officers and directors, own about 89.02% of IBO shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.